Case of anterior segment ischemia involves young adult with prior carotid artery injury.
Discover how advocacy can impact your clinical work and ultimately patient care.
Removing drops from procedure increases adherence and comfort for most patients.
Staging AMD accurately and identifying clinical features that are linked with disease progression are key.
Over the years, IKA has become an invaluable resource for eye care professionals.
Ehsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias.
Evidence-based medicine can lead to personalized care, better results for patients
Technical details, communication style key to presbyopia-correcting IOL journey.
Optimizing corneal neurotization outcomes with cryopreserved amniotic membrane.
Research can drive opportunities for patients with rare diseases
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
These tools help fill a gap that current technologies cannot achieve as effectively.
Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and laser-assisted techniques.
Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.
Ophthalmologist offers pearls for use of technology in daily work.
A discussion with Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD.
Retinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
Randomly assigned controlled trials key in increasing understanding of disease.
Surgeons can refine their workflow, partner with an optometrist.
Direct selective laser trabeculoplasty enhances the experience for both patients and physicians, he notes, while also mitigating issues related to poor adherence and ocular surface disease from topical therapy.
Wendy Lee, MD, an oculoplastics specialist and member of the program committee at EnVision Summit, shares an agenda that will include a mix of functional oculoplastics, aesthetics, and live facial rejuvenation demonstrations at the upcoming event, which will be held from February 14 to 17, 2025, at the Caribe Hilton San Juan in Puerto Rico.
Paul Badawi, co-founder and CEO of Sight Sciences, sits down with host Neda Shamie, MD, to discuss his journey into the field of eye care, what motivates him, the transformative approach to glaucoma patient care, and the spark that led him and his ophthalmologist brother, David Badawi, MD, to start the company together.
The new standard: Stabilizing keratoconus and improving vision.
Although minimally invasive procedure gives hope, additional research is required.
Adolf Fercher's 2D image of fundus paved way for today’s imaging technique.
According to Thomas Aaberg, MR, the novel therapy is geared to treat rare, debilitating eye disease.
With cases of syphilitic uveitis on the rise, recognizing its varied presentations—including optic disc edema, which may appear without other significant eye inflammation—is increasingly important for timely diagnosis and treatment.
Research can drive opportunities for patients with rare diseases
A powerful conversation about expectations can open communication and trust.